KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Current Deferred Tax Assets (2019 - 2022)

Historic Current Deferred Tax Assets for BioNTech SE (BNTX) over the last 4 years, with Q3 2022 value amounting to $73.6 million.

  • BioNTech SE's Current Deferred Tax Assets changed N/A to $73.6 million in Q3 2022 from the same period last year, while for Sep 2022 it was $73.6 million, marking a year-over-year change of. This contributed to the annual value of $55.5 million for FY2021, which is 6619.46% up from last year.
  • BioNTech SE's Current Deferred Tax Assets amounted to $73.6 million in Q3 2022.
  • In the past 5 years, BioNTech SE's Current Deferred Tax Assets registered a high of $90.6 million during Q1 2022, and its lowest value of $6.5 million during Q4 2019.
  • Over the past 4 years, BioNTech SE's median Current Deferred Tax Assets value was $55.5 million (recorded in 2021), while the average stood at $54.0 million.
  • Its Current Deferred Tax Assets has fluctuated over the past 5 years, first soared by 41450.61% in 2020, then surged by 6619.46% in 2021.
  • BioNTech SE's Current Deferred Tax Assets (Quarter) stood at $6.5 million in 2019, then skyrocketed by 414.51% to $33.4 million in 2020, then skyrocketed by 66.19% to $55.5 million in 2021, then surged by 32.66% to $73.6 million in 2022.
  • Its Current Deferred Tax Assets stands at $73.6 million for Q3 2022, versus $80.7 million for Q2 2022 and $90.6 million for Q1 2022.